{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T14:48:40Z","timestamp":1648997320801},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,11,23]],"date-time":"2016-11-23T00:00:00Z","timestamp":1479859200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Rheumatol"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1007\/s00393-016-0232-x","type":"journal-article","created":{"date-parts":[[2016,11,23]],"date-time":"2016-11-23T16:43:42Z","timestamp":1479919422000},"page":"111-117","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Evidenzbasierte Empfehlung zur Diagnostik und Therapie der axialen Spondyloarthritis"],"prefix":"10.1007","volume":"76","author":[{"given":"U.","family":"Kiltz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Rudwaleit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Sieper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Braun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,11,23]]},"reference":[{"issue":"Suppl 2","key":"232_CR1","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00393-014-1426-8","volume":"73","author":"U Kiltz","year":"2014","unstructured":"Kiltz U, Sieper J, Rudwaleit M, Kellner H, Krause D, Bohle E et\u00a0al (2014) German Society for Rheumatology S3 guidelines on axial spondyloarthritis including Bechterew\u2019s disease and early forms: 1 Introduction\/preliminary comments. Z Rheumatol 73(Suppl 2):23\u201325","journal-title":"Z Rheumatol"},{"issue":"9783","key":"232_CR2","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/S0140-6736(11)60071-8","volume":"377","author":"M Dougados","year":"2011","unstructured":"Dougados M, Baeten D (2011) Spondyloarthritis. Lancet 377(9783):2127\u20132137","journal-title":"Lancet"},{"issue":"Suppl 2","key":"232_CR3","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00393-014-1444-6","volume":"73","author":"U Kiltz","year":"2014","unstructured":"Kiltz U, Oberschelp U, Schneider E, Swoboda B, Bohm H, Winking M et\u00a0al (2014) German Society for Rheumatology S3 guidelines on axial spondyloarthritis including Bechterew\u2019s disease and early forms: 8.6 Invasive therapy. Z Rheumatol 73(Suppl 2):97\u2013100","journal-title":"Z Rheumatol"},{"issue":"12","key":"232_CR4","first-page":"2281","volume":"21","author":"A Calin","year":"1994","unstructured":"Calin A, Garrett S, Whitelock H, Kennedy LG, O\u2019Hea J, Mallorie P et\u00a0al (1994) A\u00a0new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J\u00a0Rheumatol 21(12):2281\u20132285","journal-title":"J Rheumatol"},{"issue":"Suppl 2","key":"232_CR5","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s00393-014-1428-6","volume":"73","author":"U Kiltz","year":"2014","unstructured":"Kiltz U, Rudwaleit M, Sieper J, Krause D, Chenot JF, Stallmach A et\u00a0al (2014) German Society for Rheumatology S3 guidelines on axial spondyloarthritis including Bechterew\u2019s disease and early forms: 3 Clinical symptoms. Z Rheumatol 73(Suppl 2):28\u201339","journal-title":"Z Rheumatol"},{"issue":"Suppl 2","key":"232_CR6","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s00393-014-1430-z","volume":"73","author":"U Kiltz","year":"2014","unstructured":"Kiltz U, Rudwaleit M, Sieper J, Krause D, Heiligenhaus A, Pleyer U et\u00a0al (2014) German Society for Rheumatology S3 guidelines on axial spondyloarthritis including Bechterew\u2019s disease and early forms: 5 Initial diagnosis\/referral strategy. Z Rheumatol 73(Suppl 2):44\u201348","journal-title":"Z Rheumatol"},{"issue":"9570","key":"232_CR7","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/S0140-6736(07)60635-7","volume":"369","author":"J Braun","year":"2007","unstructured":"Braun J, Sieper J (2007) Ankylosing spondylitis. Lancet 369(9570):1379\u20131390","journal-title":"Lancet"},{"issue":"4","key":"232_CR8","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780270401","volume":"27","author":"S Linden van der","year":"1984","unstructured":"van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A\u00a0proposal for modification of the New York criteria. Arthritis Rheum 27(4):361\u2013368","journal-title":"Arthritis Rheum"},{"issue":"3","key":"232_CR9","first-page":"613","volume":"27","author":"A Zink","year":"2000","unstructured":"Zink A, Braun J, Listing J, Wollenhaupt J (2000) Disability and handicap in rheumatoid arthritis and ankylosing spondylitis \u2013 results from the German rheumatological database. German Collaborative Arthritis Centers. J\u00a0Rheumatol 27(3):613\u2013622","journal-title":"J Rheumatol"},{"issue":"3","key":"232_CR10","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/art.24483","volume":"60","author":"M Rudwaleit","year":"2009","unstructured":"Rudwaleit M, Haibel H, Baraliakos X, Listing J, Marker-Hermann E, Zeidler H et al (2009) The early disease stage in axial spondylarthritis: results from the German Spondyloarthritis Inception Cohort. Arthritis Rheum 60(3):717\u2013727","journal-title":"Arthritis Rheum"},{"issue":"5","key":"232_CR11","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1002\/art.33465","volume":"64","author":"D Poddubnyy","year":"2012","unstructured":"Poddubnyy D, Haibel H, Listing J, Marker-Hermann E, Zeidler H, Braun J et al (2012) Baseline radiographic damage, elevated acute-phase reactant levels, and cigarette smoking status predict spinal radiographic progression in early axial spondylarthritis. Arthritis Rheum 64(5):1388\u20131398","journal-title":"Arthritis Rheum"},{"issue":"Suppl 2","key":"232_CR12","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00393-014-1431-y","volume":"73","author":"U Kiltz","year":"2014","unstructured":"Kiltz U, Rudwaleit M, Sieper J, Krause D, Hermann KG, Braun J (2014) German Society for Rheumatology S3 guidelines on axial spondyloarthritis including Bechterew\u2019s disease and early forms: 6 Diagnostics. Z Rheumatol 73(Suppl 2):49\u201365","journal-title":"Z Rheumatol"},{"issue":"5","key":"232_CR13","doi-asserted-by":"crossref","first-page":"893","DOI":"10.3899\/jrheum.100851","volume":"38","author":"N Montala","year":"2011","unstructured":"Montala N, Juanola X, Collantes E, Munoz-Gomariz E, Gonzalez C, Gratacos J et al (2011) Prevalence of vertebral fractures by semiautomated morphometry in patients with ankylosing spondylitis. J Rheumatol 38(5):893\u2013897","journal-title":"J Rheumatol"},{"issue":"11","key":"232_CR14","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1136\/ard.2007.083089","volume":"67","author":"IH Song","year":"2008","unstructured":"Song IH, Carrasco-Fernandez J, Rudwaleit M, Sieper J (2008) The diagnostic value of scintigraphy in assessing sacroiliitis in ankylosing spondylitis: a\u00a0systematic literature research. Ann Rheum Dis 67(11):1535\u20131540","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"232_CR15","first-page":"971","volume":"26","author":"M Dougados","year":"1999","unstructured":"Dougados M, Gueguen A, Nakache JP, Velicitat P, Zeidler H, Veys E et al (1999) Clinical relevance of C\u2011reactive protein in axial involvement of ankylosing spondylitis. J Rheumatol 26(4):971\u2013974","journal-title":"J Rheumatol"},{"issue":"4","key":"232_CR16","first-page":"980","volume":"26","author":"A Spoorenberg","year":"1999","unstructured":"Spoorenberg A, van der Heijde D, de Klerk E, Dougados M, de Vlam K, Mielants H et al (1999) Relative value of erythrocyte sedimentation rate and C\u2011reactive protein in assessment of disease activity in ankylosing spondylitis. J Rheumatol 26(4):980\u2013984","journal-title":"J Rheumatol"},{"issue":"Suppl 2","key":"232_CR17","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00393-014-1433-9","volume":"73","author":"U Kiltz","year":"2014","unstructured":"Kiltz U, Sieper J, Rudwaleit M, Kellner H, Krause D, Bohle E et\u00a0al (2014) German Society for Rheumatology S3 guidelines on axial spondyloarthritis including Bechterew\u2019s disease and early forms: 8 Therapy, 8.1 Treatment concept, 8.2 Therapy targets and strategy. Z Rheumatol 73(Suppl 2):69\u201370","journal-title":"Z Rheumatol"},{"issue":"Suppl 2","key":"232_CR18","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00393-014-1442-8","volume":"73","author":"U Kiltz","year":"2014","unstructured":"Kiltz U, Mau W, Smolenski U, Repschlager U, Bohle E, Stemmer M et\u00a0al (2014) German Society for Rheumatology S3 guidelines on axial spondyloarthritis including Bechterew\u2019s disease and early forms: 8.3 Nonpharmaceutical therapeutic measures. Z Rheumatol 73(Suppl 2):71\u201377","journal-title":"Z Rheumatol"},{"issue":"Suppl 2","key":"232_CR19","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s00393-014-1443-7","volume":"73","author":"U Kiltz","year":"2014","unstructured":"Kiltz U, Sieper J, Kellner H, Krause D, Rudwaleit M, Chenot JF et\u00a0al (2014) German Society for Rheumatology S3 guidelines on axial spondyloarthritis including Bechterew\u2019s disease and early forms: 8.4 Pharmaceutical therapy, 8.5 Evaluation of therapy success of pharmaceutical measures. Z Rheumatol 73(Suppl 2):78\u201396","journal-title":"Z Rheumatol"},{"key":"232_CR20","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1136\/ard.2011.151563","volume":"70(6","author":"D Heijde van der","year":"2011","unstructured":"van der Heijde D, Sieper J, Maksymowych WP, Dougados M, Burgos-Vargas R, Landewe R et al (2011) 2010 Update of the international ASAS recommendations for the use of anti-TNF agents in patients with axial spondyloarthritis. Ann Rheum Dis 70(6:905\u2013908","journal-title":"Ann Rheum Dis"},{"key":"232_CR21","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00393-012-1089-2","volume":"72(1","author":"U Kiltz","year":"2013","unstructured":"Kiltz U, Sieper J, Braun J (2013) ASAS recommendations on the use of TNF inhibitors for patients with axial spondyloarthritis : evaluation of the 2010 update in the German-speaking area. Z Rheumatol 72(1:81\u201388","journal-title":"Z Rheumatol"},{"key":"232_CR22","first-page":"CD004800","volume":"2","author":"J Chen","year":"2005","unstructured":"Chen J, Liu C (2005) Sulfasalazine for ankylosing spondylitis. Cochrane Database Syst Rev 2:CD004800","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"232_CR23","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1136\/ard.2006.052878","volume":"65","author":"J Braun","year":"2006","unstructured":"Braun J, Zochling J, Baraliakos X, Alten R, Burmester G, Grasedyck K et\u00a0al (2006) Efficacy of sulfasalazine in patients with inflammatory back pain due to undifferentiated spondyloarthritis and early ankylosing spondylitis: a\u00a0multicentre randomised controlled trial. Ann Rheum Dis 65(9):1147\u20131153","journal-title":"Ann Rheum Dis"},{"key":"232_CR24","first-page":"CD004524","volume":"4","author":"J Chen","year":"2006","unstructured":"Chen J, Liu C, Lin J (2006) Methotrexate for ankylosing spondylitis. Cochrane Database Syst Rev 4:CD004524","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"232_CR25","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/rheumatology\/kep174","volume":"49","author":"B Vander Cruyssen","year":"2010","unstructured":"Vander Cruyssen B, Munoz-Gomariz E, Font P, Mulero J, de Vlam K, Boonen A et al (2010) Hip involvement in ankylosing spondylitis: epidemiology and risk factors associated with hip replacement surgery. Rheumatology (Oxford) 49(1):73\u201381","journal-title":"Rheumatology (Oxford)"},{"issue":"Suppl 2","key":"232_CR26","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00393-014-1445-5","volume":"73","author":"U Kiltz","year":"2014","unstructured":"Kiltz U, Mau W, Repschlager U, Bohle E, Braun J (2014) German Society for Rheumatology S3 guidelines on axial spondyloarthritis including Bechterew\u2019s disease and early forms: 8.7 Rehabilitation. Z Rheumatol 73(Suppl 2):101\u2013103","journal-title":"Z Rheumatol"},{"issue":"Suppl 2","key":"232_CR27","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s00393-014-1434-8","volume":"73","author":"U Kiltz","year":"2014","unstructured":"Kiltz U, Mau W, Repschlager U, Bohle E, Braun J (2014) German Society for Rheumatology S3 guidelines on axial spondyloarthritis including Bechterew\u2019s disease and early forms: 9 International classification of functioning, disability and health (ICF). Z Rheumatol 73(Suppl 2):104\u2013108","journal-title":"Z Rheumatol"},{"issue":"1","key":"232_CR28","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1136\/ard.2008.104117","volume":"69","author":"A Boonen","year":"2010","unstructured":"Boonen A, Braun J, van der Horst Bruinsma IE, Huang F, Maksymowych W, Kostanjsek N et\u00a0al (2010) ASAS\/WHO ICF Core Sets for ankylosing spondylitis (AS): how to classify the impact of AS on functioning and health. Ann Rheum Dis 69(1):102\u2013107","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 2","key":"232_CR29","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00393-014-1435-7","volume":"73","author":"U Kiltz","year":"2014","unstructured":"Kiltz U, Stemmer M, Braun J (2014) German Society for Rheumatology S3 guidelines on axial spondyloarthritis including Bechterew\u2019s disease and early forms: 10 Patient information. Z Rheumatol 73(Suppl 2):109\u2013111","journal-title":"Z Rheumatol"},{"issue":"26","key":"232_CR30","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1056\/NEJMoa1505066","volume":"373","author":"D Baeten","year":"2015","unstructured":"Baeten D, Sieper J, Braun J, Baraliakos X, Dougados M, Emery P et al (2015) Secukinumab, an Interleukin-17A Inhibitor. N Engl J Med 373(26):2534\u20132548","journal-title":"N Engl J Med"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-016-0232-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00393-016-0232-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-016-0232-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T04:19:05Z","timestamp":1498364345000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00393-016-0232-x"}},"subtitle":["S3-Leitlinie der Deutschen Gesellschaft f\u00fcr Rheumatologie (DGRh) in Kooperation mit der Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF)"],"short-title":[],"issued":{"date-parts":[[2016,11,23]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["232"],"URL":"https:\/\/doi.org\/10.1007\/s00393-016-0232-x","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,23]]}}}